Transplanted Late Outgrowth Endothelial Progenitor Cells as Cell Therapy Product for Stroke

Stem Cell Reviews and Reports

Volumn 7, Issue 1, 2011, Pages 208-220

  Moubarik, Chahrazad ^a   Guillet, Benjamin ^a   Youssef, Bennis ^a   Codaccioni, Jean Laurent ^b   Piercecchi, Marie Dominique ^a   Sabatier, Florence ^a,c   Lionel, Pellegrini ^b   Dou, Laetitia ^a   Foucault Bertaud, Alexandrine ^a   Velly, Lionel ^b   Dignat George, Françoise ^a,c   Pisano, Pascale ^a  

^a INSERM   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Angiogenesis; Apoptosis; Late endothelial progenitors; Stroke

Indexed keywords

ANIMALIA; RATTUS;

EID: 78751644881     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9157-y     Document Type: Article

References (49)

1. Rouhl, R. P., van Oostenbrugge, R. J., Damoiseaux, J., Cohen Tervaert, J. W., & Lodder, J. (2008). Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke, 39, 2158-65.
2. Chen, J., Li, Y., Wang, L., Lu, M., Zhang, X., & Chopp, M. (2001). Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. Journal of the Neurological Sciences, 189, 49-57.
3. Chen, J., Sanberg, P. R., Li, Y., Wang, L., Lu, M., Willing, A. E., et al. (2001). Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke, 32, 2682-8.
4. Li, Y., Chen, J., Wang, L., Lu, M., & Chopp, M. (2001). Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology, 56, 1666-72.
5. Newcomb, J. D., Ajmo, C. T., Jr., Sanberg, C. D., Sanberg, P. R., Pennypacker, K. R., & Willing, A. E. (2006). Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplantation, 15, 213-23.
6. Bang, O. Y., Lee, J. S., Lee, P. H., & Lee, G. (2005). Autologous mesenchymal stem cell transplantation in stroke patients. Annals of Neurology, 57, 874-82.
7. Hur, J., Yoon, C. H., Kim, H. S., Choi, J. H., Kang, H. J., Hwang, K. K., et al. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neoangiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 288-93.
8. Yoder, M. C., Mead, L. E., Prater, D., Krier, T. R., Mroueh, K. N., Li, F., et al. (2007). Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 109, 1801-9.
9. Ingram, D. A., Mead, L. E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K., et al. (2004). Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood, 104(9), 2752-60.
10. Wechsler, L., Steindler, D., Borlongan, C., Chopp, M., Savitz, S., Deans, R., et al. (2009). Stem cell therapies as an emerging paradigm in stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke, 40(2), 510-5.
11. Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20(1), 84-91.
12. Codaccioni, J. L., Velly, L., Moubarik, C., Bruder, N., Pisano, P., & Guillet, B. (2009). Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology, 110(6), 1271-8.
13. Delorme, B., Basire, A., Gentile, C., Sabatier, F., Monsonis, F., Desouches, C., et al. (2005). Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thrombosis and Haemostasis, 94, 1270-9.
14. Jaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. Journal of Clinical Investigation, 52(11), 2745-56.
15. Jourde-Chiche, N., Dou, L., Sabatier, F., Calaf, R., Cerini, C., Robert, S., et al. (2009). Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients. Journal of Thrombosis and Haemostasis, 7(9), 1576-84.
16. Aicher, A., Brenner, W., Zuhayra, M., Badorff, C., Massoudi, S., Assmus, B., et al. (2003). Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labelling. Circulation, 107, 2134-9.
17. Lin, T. N., He, Y. Y., Wu, G., Khan, M., & Hsu, C. Y. (1993). Effect of brain oedema on infarct volume in a focal cerebral ischemia model in rats. Stroke, 24, 117-21.
18. Dubowitz, V., Sewry, C. A., & Fitzsimons, R. B. (1985). Muscle biopsy: a practical approach (2nd ed., pp. 504-559). Philadelphia: Bailliere -Tindall.
19. Zhang, L., Yang, R., & Han, Z. C. (2006). Transplantation of umbilical cord blood-derived endothelial progenitor cells: a promising method of therapeutic revascularisation. European Journal of Haematology, 76, 1-8.
20. Corselli, M., Parodi, A., Mogni, M., Sessarego, N., Kunkl, A., Dagna-Bricarelli, F., et al. (2008). Clinical scale ex vivo expansion of cord blood-derived outgrowth endothelial progenitor cells is associated with high incidence of karyotype aberrations. Experimental Hematology, 36, 340-9.
21. Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., et al. (2002). Human marrow stromal cell therapy for stroke in rat, neurotrophins and functional recovery. Neurology, 59, 514-23.
22. Chen, J., Li, Y., Katakowski, M., Chen, X., Wang, L., Lu, D., et al. (2003). Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. Journal of Neuroscience Research, 73, 778-86.
23. Vendrame, M., Cassady, J., Newcomb, J., Butler, T., Pennypacker, K. R., Zigova, T., et al. (2004). Infusion of human umbilical cord blood cells in rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke, 35, 2390-5.
24. Iihoshi, S., Honmou, O., Houkin, K., Hashi, K., & Kocsis, J. D. (2004). A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Research, 1007, 1-9.
25. Mokudai, T., Ayoub, I. A., Sakakibara, Y., Lee, E. J., Ogilvy, C. S., & Maynard, K. I. (2000). Delayed treatment with nicotinamide (Vitamin B3) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke, 31, 1679-85.
26. Schöller, K., Zausinger, S., Baethmann, A., & Schmid-Elsaesser, R. (2004). Neuroprotection in ischemic stroke-combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia. Brain Research, 1023, 272-8.
27. Sobrino, T., Hurtado, O., Moro, M. A., Rodríguez-Yáñez, M., Castellanos, M., Brea, D., et al. (2007). The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke, 38(10), 2759-64.
28. Di Stefano, R., Barsotti, M. C., Armani, C., Santoni, T., Lorenzet, R., Balbarini, A., et al. (2009). Human peripheral blood endothelial progenitor cells synthesize and express functionally active tissue factor. Thrombosis Research, 123(6), 925-30.
29. Zampetaki, A., Kirton, J. P., & Xu, Q. (2008). Vascular repair by endothelial progenitor cells. Cardiovascular Research, 78(3), 413-21.
30. Zhang, Z. G., & Chopp, M. (2009). Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurology, 8(5), 491-500.
31. He, T., Peterson, T. E., & Katusic, Z. S. (2005). Paracrine mitogenic effect of human endothelial progenitor cells: role of interleukin-8. American Journal of Physiology. Heart and Circulatory Physiology, 289, 968-72.
32. Bechara, C., Chai, H., Lin, P. H., Yao, Q., & Chen, C. (2007). Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Medical Science Monitor, 13(6), RA87-RA90.
33. Krupinski, J., Issa, R., Bujny, T., Slevin, M., Kumar, P., Kumar, S., et al. (1997). A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke, 28(3), 564-73.
34. Liu, X. S., Zhang, Z. G., Zhang, R. L., Gregg, S. R., Wang, L., Yier, T., et al. (2007). Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke. Journal of Neuroscience Research, 85(10), 2120-5.
35. Candelario-Jalil, E., Yang, Y., & Rosenberg, G. A. (2009). Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience, 158(3), 983-94. Review.
36. Sun, D., Bullock, M. R., Altememi, N., Zhou, Z., Hagood, S., Rolfe, A., et al. (2010). The effect of epidermal growth factor in the injured brain after trauma in rats. Journal of Neurotrauma, 27, 923-38.
37. Chen, J., Zhang, Z. G., Li, Y., Wang, L., Xu, Y. X., Gautam, S. C., et al. (2003). Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic inner boundary zone after stroke in rats. Circulation Research, 92, 692-9.
38. Mahmood, A., Lu, D., Qu, C., Goussev, A., & Chopp, M. (2006). Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. Journal of Neurosurgery, 104(2), 272-7.
39. Mahmood, A., Lu, D., & Chopp, M. (2004). Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. Journal of Neurotrauma, 21(1), 33-9.
40. Wang, C. H., Cheng, W. J., Yang, N. I., Kuo, L. T., Hsu, C. M., Yeh, H. I., et al. (2008). Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 54-60.
41. Hau, S., Reich, D. M., Scholz, M., Naumann, W., Emmrich, F., Kamprad, M., et al. (2008). Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neuroscience, 9, 30.
42. Kooijman, R., Sarre, S., Michotte, Y., & De Keyser, J. (2009). Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke? Stroke, 40(4), e83-8.
43. Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001). Regulation of cell survival by secreted proneurotrophins. Science, 294(5548), 1945-8.
44. Deng, Y. B., Ye, W. B., Hu, Z. Z., Yan, Y., Wang, Y., Takon, B. F., et al. (2010). Intravenously administered BMSCs reduce neuronal apoptosis and promote neuronal proliferation through the release of VEGF after stroke in rats. Neurological Research, 32(2), 148-56.
45. Mouw, G., Zechel, J. L., Zhou, Y., Lust, W. D., Selman, W. R., & Ratcheson, R. A. (2002). Caspase-9 inhibition after focal cerebral ischemia improves outcome following reversible focal ischemia. Metabolic Brain Disease, 17, 143-51.
46. Fedoroff, S., Berezovskaya, O., & Maysinger, D. (1997). Role of colony stimulating factor-1 in brain damage caused by ischemia. Neuroscience and Biobehavioral Reviews, 21, 187-91.
47. Dinkel, K., Dhabhar, F. S., & Sapolsky, R. M. (2004). Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures. Proceedings of the National Academy of Sciences of the USA, 101, 331-6.
48. Li, Y., Chen, J., Zhang, C. L., Wang, L., Lu, D., Katakowski, M., et al. (2005). Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia, 49, 407-17.
49. Chopp, M., Li, Y., & Zhang, Z. (2009). Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke, 40, S143-S145.